Translation of an allogeneic tissue-engineered product for the treatment of focal lesions of articular cartilage

To evaluate the safety and regenerative capacity of a tissue-engineered product consisting of a type I/III collagen construct with allogeneic stromal stem cells from Wharton's jelly in an ovine experimental model and to transfer the knowledge obtained from the animal study to humans